Dr Reddy's CEO 'optimistic' about Trump administration, says our positioning of India is favourable

Dr Reddy's Laboratories CEO expressed optimism about the Trump administration, projecting an edge due to ongoing U.S.-China tensions. The company's U.S. revenues increased slightly due to new launches despite facing pricing pressures. Consolidated net profit rose by 2% for the third quarter of 2024, driven by strong performance across markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/n3BpQZh
via IFTTT